Department of Surgery, Renaissance School of Medicine, Stony Brook, NY; Division of Vascular Surgery, Department of Surgery, Renaissance School of Medicine, Stony Brook, NY.
Department of Surgery, Renaissance School of Medicine, Stony Brook, NY.
Ann Vasc Surg. 2022 Feb;79:122-126. doi: 10.1016/j.avsg.2021.07.034. Epub 2021 Oct 10.
Coronavirus disease 2019 (COVID-19) has been widely reported to be associated with increased risk of Venous Thromboembolism, both deep vein thrombosis (DVT) and pulmonary embolism. A rare and extreme manifestation of DVT is Phlegmasia cerulea dolens, characterized by poor tissue perfusion due to marked limb swelling which can progress to limb and life-threatening venous gangrene. We report the case of a 53-year-old man with severe SARS-CoV2 pneumonia who developed acute iliofemoral DVT leading to acute limb ischemia due to Phlegmasia cerulea dolens. The patient underwent successful emergent fasciotomy and mechanical thrombectomy with removal of extensive thrombus burden and restoration of normal venous circulation. Our case highlights the importance of clinical vigilance and early implementation of therapeutic interventions to avoid adverse outcomes in patients who develop SARS-CoV2 induced Venous Thromboembolism complications.
新型冠状病毒病 2019（COVID-19）已被广泛报道与静脉血栓栓塞症（DVT 和肺栓塞）的风险增加有关。DVT 的一种罕见且极端表现是青肿性疼痛性静脉炎，其特征是由于肢体肿胀明显导致组织灌注不良，可进展为肢体和危及生命的静脉坏疽。我们报告了一例 53 岁的男性，患有严重的严重急性呼吸综合征冠状病毒 2 型（SARS-CoV2）肺炎，发生急性髂股 DVT，导致青肿性疼痛性静脉炎引起的急性肢体缺血。患者成功接受了紧急筋膜切开术和机械血栓切除术，清除了大量血栓负荷并恢复了正常的静脉循环。我们的病例强调了临床警惕性和早期实施治疗干预的重要性，以避免发生 SARS-CoV2 诱导的静脉血栓栓塞并发症的患者出现不良结局。
